STOCK TITAN

Octavio Espinoza sells shares under 10b5-1 plan (LGND)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

LGND filing: Notice of proposed sale under Rule 144 reporting planned dispositions of Common Stock by an insider. The excerpt lists 10b5-1 sales on 03/04/2026 for 13,423 shares and a sale on 12/12/2025 for 1,804 shares. It also shows exercises of stock options on 03/11/2026 (reported 2,405 shares) and earlier on 12/16/2025 (652 shares). The transactions are reported as planned 10b5-1 sales and option exercises; cash consideration amounts are shown for each sale row.

Positive

  • None.

Negative

  • None.

Insights

Routine Rule 144 notice of planned insider dispositions under a trading plan.

The filing records 10b5-1 sales and option exercises with exact share counts: 13,423 shares on 03/04/2026 and 1,804 shares on 12/12/2025. It lists option exercises on 03/11/2026 and 12/16/2025.

These entries align with standard compliance disclosures; cash amounts are presented per row. Subsequent public filings will show consummation details if required.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What transactions does LGND's Form 144 report?

The Form 144 reports planned insider sales and option exercises by an executive. It lists 10b5-1 sales of 13,423 shares on 03/04/2026 and 1,804 shares on 12/12/2025, plus option exercises of 2,405 and 652 shares on 03/11/2026 and 12/16/2025.

Who is identified as the selling party in the LGND filing?

The filing identifies Octavio Espinoza with an address in Jupiter, FL, as the reporting person. The record shows his 10b5-1 sales and related cash amounts in the rows provided, consistent with a reporting insider using a pre-arranged trading plan.

Are the LGND sales reported as part of a 10b5-1 plan?

Yes, the Form 144 rows explicitly label the sales as 10b5-1 Sales. The entries show planned dispositions on 03/04/2026 and 12/12/2025, indicating these transactions were executed under a pre-arranged trading arrangement as disclosed in the excerpt.

Do the Form 144 rows show cash amounts received from the sales?

Yes, each sale row lists cash consideration values alongside share counts. For example, the 13,423 share sale on 03/04/2026 shows $2,762,822.25 and the 1,804 share sale on 12/12/2025 shows $339,711.24 in the provided excerpt.
Ligand Pharma

NASDAQ:LGND

View LGND Stock Overview

LGND Rankings

LGND Latest News

LGND Latest SEC Filings

LGND Stock Data

4.41B
19.18M
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO